Daily non-political popular news in brief.

Which segments of the gastrointestinal tract does Salmonella enteritidis penetrate?

Salmonella enteritidis is one of the main causes of food-borne illness worldwide. The virulence of this organism depends on its ability to penetrate into the Payers patches, and survive and multiply. Thus, knowledge about the port of entry may lead to new insights into prevention and therapy. A research group led by Dr. Cheng has found the jejunum, ileum and cecum were the primary sites of invasion in mice after oral challenge.

Read more »

Keywords: segments, gastrointestinal, tract, salmonella, enteritidis, penetrate, segment, enteritidi

« Previous | Next »

Similar news on "Which segments of the gastrointestinal tract does Salmonella enteritidis penetrate?":

1. ASGE offers guidelines on endoscopic treatment of dyspepsia
   12-21-2007 · EurekAlert!
   The American Society for Gastrointestinal Endoscopy has issued guidelines for the role of endoscopy in treating dyspepsia, discomfort thought to arise from the upper-gastrointestinal tract, which affects a fourth of the population in Western countries. The guidelines, prepared by ASGE's Standards of Practice Committee, appear in the December issue of Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy.
   Similar news · Read more »
   
2. Cedars-Sinai researchers on multicenter team linking gene mutation to Crohn's disease
   10-26-2006 · EurekAlert!
   The North American IBD Genetics Consortium has linked a gene mutation to the development of Crohn's disease, a chronic, relapsing inflammatory disorder of the gastrointestinal tract that affects 100 to 150 of every 100,000 people of European ancestry. The consortium is composed of IBD genetics research groups from seven centers in North America, including Cedars-Sinai Medical Center, and this effort was led by teams at Yale University and the University of Pittsburgh.
   Similar news · Read more »
   
3. Suffering from chronic constipation?
   11-22-2006 · EurekAlert!
   New research has found that a new medication, tegaserod, is effective in treating nearly all symptoms associated with chronic constipation, a common disorder of the gastrointestinal tract that affects approximately 15 percent of the Western population at any one time. Tegaserod is currently the only drug aside from laxatives found to be effective at treating such a wide variety of symptoms. This research is published in the American Journal of Gastroenterology.
   Similar news · Read more »
   
4. Studies assess effectiveness of serotonin and nerve stimulants on irritable bowel syndromes
   05-21-2007 · EurekAlert!
   Studies have shown that gastrointestinal tract function is often influenced by specific stimulants or reactors, which sometimes cause irritable bowel syndrome or constipation. Two studies presented today at Digestive Disease Week 2007 take a closer look at GI stimulation, including one examining the role of serotonin and reactions to certain types of foods and another looking at the potential therapeutic value of nerve stimulation for constipation. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
   Similar news · Read more »
   
5. A low prevalence of H pylori in HIV-positive patients
   10-16-2007 · EurekAlert!
   Human immunodeficiency virus infection is a challenging disease worldwide. The gastrointestinal tract has long been recognized as a major site of AIDS-related diseases, and researchers have long been seeking the characteristic causing this. A research group in China has found that the prevalence of H pylori infection and peptic ulcer in HIV-positive patients was lower than that of the general population.
   Similar news · Read more »
   
6. LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
   10-17-2007 · EurekAlert!
   According to a study using a dynamic in vitro gastrointestinal tract system, Shire plc's ulcerative colitis drug LIALDA (mesalamine) demonstrated a delivery system where the majority of the drug's active ingredient, 5-aminosalicyclic acid, is released over a prolonged period in the simulated colon. The colon is the site of inflammation in ulcerative colitis.
   Similar news · Read more »
   
7. LIALDA demonstrates prolonged release of mesalamine
   10-17-2007 · EurekAlert!
   According to a study using a dynamic in vitro gastrointestinal tract system, Shire plc's ulcerative colitis drug LIALDA (mesalamine) demonstrated a delivery system where the majority of the drug's active ingredient, 5-aminosalicyclic acid, is released over a prolonged period in the simulated colon. The colon is the site of inflammation in ulcerative colitis.
   Similar news · Read more »
   
8. MDCT accurately locates bowel perforation avoiding need for exploratory surgery
   01-24-2007 · EurekAlert!
   Multidetector CT (MDCT) without the use of contrast media can show the precise site of a bowel perforation, avoiding the need for surgeons to do exploratory surgery of the patient's gastrointestinal tract to locate the problem, a new study shows.
   Similar news · Read more »
   
9. LIALDA (TM) demonstrates prolonged release of mesalamine
   10-17-2007 · EurekAlert!
   According to a study using a dynamic in vitro gastrointestinal tract system, Shire plc's ulcerative colitis drug LIALDA (mesalamine) demonstrated a delivery system where the majority of the drug's active ingredient, 5-aminosalicyclic acid, is released over a prolonged period in the simulated colon. The colon is the site of inflammation in ulcerative colitis.
   Similar news · Read more »
   
10. The largest colonic lipoma to date
    10-26-2007 · EurekAlert!
    Colonic lipoma is an uncommon tumor of the gastrointestinal tract. Most cases are asymptomatic, with a small tumor size, and do not need any special treatment. However, Dr. Li-Sheng Jiang and Dr. Li Jiang in China have encountered one patient with a giant colonic lipoma, with a maximum diameter of 8.5 cm, which exhibited significant symptoms. To the best of their knowledge, this colonic lipoma is the largest one so far.
    Similar news · Read more »